Skip to Content

Michael London

Founding Partner Douglas London
Douglas London

Michael A. London is one of the founding partners of the law firm Douglas & London, P.C. Since obtaining his law degree, he has devoted his entire career to representing consumers and injury victims, primarily in mass tort settings. His practice area has always focused on products liability and complex litigation with an emphasis on pharmaceutical and medical device litigation.

Representative Matters:

  • Vice-Chair of Plaintiffs’ Steering Committee, In re: Zyprexa, resolved, $700 million settlement of approximately 8,000 claims.
  • Co-Lead Counsel of Plaintiffs, Steering Committee, In re: Yasmin and Yaz, resolved with the defendants paying over $2 billion for all claims.
  • Co-Lead Counsel and Liaison Counsel for Plaintiffs, Steering Committee, In re: Bayer Combination Aspirin Products, resolved, $15 million class settlement.
  • Co-Lead Counsel of Plaintiffs, Steering Committee, In re: Pradaxa, resolved, $650 million settlement of approximately 4,000 claims.
  • Liaison Counsel and Plaintiffs, Executive Committee Member, In re: Ortho Evra, resolved, individual confidential settlements of approximately 3,000 claims in federal and state courts.
  • Chairperson of the Plaintiffs Executive Committee, In re: Testosterone Replacement, all six of the manufacturing defendants have resolved the approximately 7,000 claims in the MDL.
  • Co-Liaison Counsel for all Plaintiffs, In re: Levaquin, resolved, individual confidential settlements of hundreds of claims in federal and state courts.
  • Co-Lead Counsel of Plaintiffs, Steering Committee, In re: E.I. du Pont, resolved, $671 million settlement of approximately 3,600 claims.
  • Co-Lead Counsel of Plaintiffs, Steering Committee, In re: Invokana, resolutions pending via individual confidential settlements of approximately 2,000 claims.
  • Co-Lead Counsel of Plaintiffs, Executive Committee, In re: Aqueous Film-Forming Foam Products Liability Litigation, MDL-2873, pending.
  • Chair, Plaintiffs’ Executive Committee, In re: Davol, Inc./CR Bard Inc., Polypropylene Hernia Mesh, pending.
  • Trial counsel in multiple tobacco trials, including the first successful verdict over $20 million.
  • Other court-appointments of the general Plaintiff Steering Committee involve In re: Kugel Mesh Hernia, resolved; In re: Heparin, resolved; In re: Imagitas Inc., resolved; In re: Light Cigarettes Marketing, resolved; In re: Bextra/Celebrex, resolved; In re: Zimmer NexGen Knee, resolved; In re: Denture Cream, resolved; and In re: DePuy Orthopaedics, Inc., ASR Hip Implant, resolved.
Related Events
:   
8:30 am
9:15 am